Topics

Vifor Pharma, Evotec form joint venture focused on renal cancer

04:44 EST 7 Nov 2019 | SmartBrief

Vifor Pharma will invest $28 million in a joint venture with Evotec to create new renal therapy targets.  -More

Original Article: Vifor Pharma, Evotec form joint venture focused on renal cancer

NEXT ARTICLE

More From BioPortfolio on "Vifor Pharma, Evotec form joint venture focused on renal cancer"

Quick Search

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Renal disease
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...